ErgomarSublingual (TerSera Therapeutics, LLC)
Welcome to the PulseAid listing for the Ergomar drug offered from TerSera Therapeutics, LLC. This Ergotamine Derivative [EPC],Ergotamines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | TerSera Therapeutics, LLC |
| NON-PROPRIETARY NAME: | Ergotamine Tartrate |
| SUBSTANCE NAME: | ERGOTAMINE TARTRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Ergotamine Derivative [EPC],Ergotamines [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-09-20 |
| END MARKETING DATE: | 0000-00-00 |
Ergomar Sublingual HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ergomar Sublingual from TerSera Therapeutics, LLC |
| LABELER NAME: | TerSera Therapeutics, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/1) |
| START MARKETING DATE: | 2016-09-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70720-120_dabfe558-c0f1-458c-8a4d-6114eb907296 |
| PRODUCT NDC: | 70720-120 |
| APPLICATION NUMBER: | ANDA087693 |
Other ERGOTAMINE TARTRATE Pharmaceutical Manufacturers / Labelers:
